Abbott Labs (ABT)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Abbott Labs | ABT | Healthcare | Medical Devices | 93 | 9.6% |
| Current Price ( 9/28 4:00PM EDT) | $98.12 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 40,226.0 | |||
| Sales Growth Forecast | 5.6% | |||
| Net Profit Margin | 22.7% | |||
| Projected Shares Outstanding | 1,740.80 | |||
| EPS - Five year Forecast | $6.87 | |||
| Average P/E Ratio | 21.0 | |||
| Projected Average Price | $144.33 | |||
| Price Appreciation (Annualized) | 8.0% | |||
| Annual Dividend Yield | 1.6% | |||
| Projected Annual Return | 9.6% | |||
| Quality | ||||
| Financial Strength | 94 | 23.4 | ||
| EPS Stability | 96 | 24.1 | ||
| Industry Sales Growth Rate | 11.5% | 6.0 | ||
| Industry Net Profit Margin | 15.5% | 18.3 | ||
| Calculated Quality Rating | 74.2 | |||
| Fool CAPS | ||||
Total Players
2484
Outperforms
96
Underperforms
All-Stars (487)
473
Outperforms (97%)
14
Underperforms
|
||||
| Fundamental Data Updated: 08/11/2023 | ||||